Hem › Dermatomyosit › Kalifornien
Kliniska studier för Dermatomyosit i Kalifornien
9 studier för Dermatomyosit söker deltagare vid platser i Kalifornien.
Officiell studietext (engelska)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Irvine
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of California Irvine - Accepting Adult Patients, Orange
- University of California, San Francisco Benioff Children's Hospital - Accepting Young Adult and Juvenile Patients, San Francisco
RekryterarFas 2/3
Ålder 6 till 75 · Alla kön · Uppdaterad 17 sep. 2026 · NCT06154252A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, La Jolla
- Research Site, Sacramento
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 15 sep. 2026 · NCT06916806A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- 200 UCLA Medical Plaza, Los Angeles
- UCLA Clinical & Translational Research Center (CTRC), Los Angeles
- UCLA, Los Angeles
- och 1 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104FT839 in Autoimmune Diseases
- Providence Medical Foundation, Fullerton
RekryterarFas 1/2
Ålder 18 till 70 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07800871Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of California-Irvine, Orange
RekryterarFas 1
Ålder 18 till 85 · Alla kön · Uppdaterad 22 juli 2026 · NCT06371417Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
- Stanford University, Palo Alto
- Stanford University, Stanford
RekryterarFas 1
Ålder 25 till 72 · Alla kön · Uppdaterad 21 maj 2025 · NCT06298019Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.